{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:29:03Z","timestamp":1792412943214,"version":"4.4.0"},"reference-count":20,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1525,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/art.30367","type":"journal-article","created":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T20:12:09Z","timestamp":1300997529000},"page":"2007-2013","source":"Crossref","is-referenced-by-count":148,"title":["High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: Development and validation of a methotrexate intolerance severity score"],"prefix":"10.1002","volume":"63","author":[{"given":"Maja","family":"Bulatovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes W.","family":"Heijstek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Verkaaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H. Pieter","family":"van Dijkhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wineke","family":"Armbrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther P. A.","family":"Hoppenreijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wietse","family":"Kuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine C. G.","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerben","family":"Sinnema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin M. A.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,29]]},"reference":[{"key":"10.1002\/art.30367-BIB1|cit1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/art.30367-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/art.30367-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30367-BIB4|cit4","first-page":"2501","article-title":"Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis","volume":"31","author":"Ortiz-Alvarez","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30367-BIB5|cit5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1521-6942(02)90234-2","article-title":"Advanced therapy for juvenile arthritis","volume":"16","author":"Murray","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1002\/art.30367-BIB6|cit6","first-page":"480","article-title":"Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study","volume":"25","author":"Van der Meer","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1002\/art.30367-BIB7|cit7","first-page":"2184","article-title":"Folinic acid to prevent side effects of methotrexate in juvenile rheumatoid arthritis","volume":"23","author":"Alarcon","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30367-BIB8|cit8","first-page":"625","article-title":"Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis","volume":"17","author":"Ravelli","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1002\/art.30367-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7","article-title":"Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study","volume":"44","author":"Van Ede","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30367-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","article-title":"Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30367-BIB11|cit11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.6004\/jnccn.2007.0006","article-title":"Behavioral interventions in treating anticipatory nausea and vomiting","volume":"5","author":"Figueroa-Moseley","year":"2007","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1002\/art.30367-BIB12|cit12","first-page":"547","article-title":"Anticipatory nausea and vomiting in pediatric cancer patients","volume":"75","author":"Dolgin","year":"1985","journal-title":"Pediatrics"},{"key":"10.1002\/art.30367-BIB13|cit13","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30367-BIB14|cit14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.rhu.0000173616.81928.44","article-title":"Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire","volume":"11","author":"Brunner","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1002\/art.30367-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","article-title":"Medical treatment of juvenile idiopathic arthritis","volume":"294","author":"Hashkes","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/art.30367-BIB16|cit16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/adc.88.3.197","article-title":"Use of methotrexate in juvenile idiopathic arthritis","volume":"88","author":"Ramanan","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1002\/art.30367-BIB17|cit17","first-page":"179","article-title":"The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate","volume":"31","author":"Alsufyani","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30367-BIB18|cit18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/adc.88.10.931","article-title":"Incorporating psychological approaches into routine paediatric venepuncture","volume":"88","author":"Duff","year":"2003","journal-title":"Arch Dis Child"},{"issue":"Suppl 8A","key":"10.1002\/art.30367-BIB19|cit19","doi-asserted-by":"crossref","first-page":"106S","DOI":"10.1016\/S0002-9343(01)00849-X","article-title":"Central neurocircuitry associated with emesis","volume":"111","author":"Hornby","year":"2001","journal-title":"Am J Med"},{"key":"10.1002\/art.30367-BIB20|cit20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2165\/00003495-199753020-00003","article-title":"Physiology of chemotherapy-induced emesis and antiemetic therapy: predictive models for evaluation of new compounds","volume":"53","author":"Veyrat-Follet","year":"1997","journal-title":"Drugs"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30367","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/art.30367\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T22:02:58Z","timestamp":1625090578000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,29]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30367","relation":{},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,29]]}}}